Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD
Impact of Feedback on Physical Activity Levels and Health-related Outcomes of Patients With COPD During Pulmonary Rehabilitation
The aim of this study is to investigate whether providing feedback on physical activity (PA) levels to patients with Chronic Obstructive Pulmonary Disease (COPD) is feasible and enhances daily PA and health-related outcomes during pulmonary rehabilitation (PR).
Patients will participate in a 12-week PR program and a PA-focused intervention. Patients' daily PA will be monitored during the first (W1), seventh (W7) and 12th (W12) weeks of the PR program using the activity monitors GT3X+ (ActiGraph, Pensacola, FL) and feedback will be given to them in the following weeks. Each participant will also receive individualised recommendations to improve or maintain their PA levels, based on the results of the previous week.
It is expected that, by receiving individualised feedback and goals regarding their PA levels during the PR program, patients with COPD will become more active and improve their health-related outcomes.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Patients with Chronic Obstructive Pulmonary Disease (COPD) present lower levels of physical activity (PA), which have been associated with adverse outcomes including increased healthcare utilisation and reduced survival. Thus, improving PA levels has become one of the main goals of COPD research.
Pulmonary rehabilitation (PR) is a cornerstone of COPD management with well-documented effects on exercise capacity and quality of life. However, its effects in increasing patients' physical activity (PA) levels are limited. Previous research has suggested that PR with PA monitoring and feedback may be a suitable approach to increase and/or maintain patients' PA levels.
Patients with COPD will participate in a 12-week PR program plus a PA-focused intervention. Daily PA will be measured using activity monitors GT3X+ (ActiGraph, Pensacola, FL) on weeks (W) 1, 7 and 12 and feedback will be given to participants in the following weeks regarding: daily steps; time spent in sedentary, light and moderate-to-vigorous (MVPA) intensity activities.
The impact of the intervention will be explored using a mixed-methods approach.
Assessments will be conducted immediately before (W1) and after (W12) the PR program. Breathlessness, exercise capacity, functional balance, peripheral muscle strength and health-related quality of life will be assessed in both time points.
Descriptive statistics will be used to characterise the sample. To analyse changes in outcome measures, data from the two time points will be compared. Correlations between PA data and health-related outcomes will be performed at W1 and using the change scores (i.e., W12-W1).
Patients will also be invited to attend focus groups after the intervention to assess their perspectives about the use of activity monitors and the feedback given.
This is a pilot study which will inform the main study (including the sample size calculation).
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- clinical diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
- ≥ 18 years old
- clinical stability for 1 month prior to the study (no hospital admissions or exacerbations)
Exclusion Criteria:
- presence of severe psychiatric, neurologic or musculoskeletal conditions and/or unstable cardiovascular disease
- participation in regular exercise prior to the study
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Activity group
Pulmonary rehabilitation plus physical activity intervention
|
Patients will enrol in a 12-week PR program comprising exercise training (3 times per week) and psychosocial support and education sessions (once a week).
Patients will also have their PA levels monitored on weeks (W) 1, 7 and 12 and receive feedback in the following weeks.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in physical activity levels
Tidsram: weeks 1, 7 and 12
|
Physical activity data will be collected using a triaxial accelerometer.
Number of steps per day and time spent in sedentary, light and moderate-to-vigorous intensity activities will be assessed.
Time spent in different postures (i.e., standing, sitting and lying) will also be determined.
|
weeks 1, 7 and 12
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in exercise capacity
Tidsram: immediately before (week 1) and after (week 12) the PR program
|
Exercise tolerance will be assessed with the 6-minute walk test, following the American Thoracic Society guidelines.
The maximal distance walked during 6 minutes and the associated respiratory symptoms will be collected.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in peripheral muscle strength
Tidsram: immediately before (week 1) and after (week 12) the PR program
|
Isometric muscle strength of the upper and lower limbs will be assessed with the 10-RM following the American College of Sports Medicine guidelines.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in activities limitation resulting from breathlessness
Tidsram: immediately before (week 1) and after (week 12) the PR program
|
The Modified British Medical Research Council questionnaire comprises five grades (statements) in a scale from 0 to 4, with higher grades indicating greater perceived respiratory limitation.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in functional balance
Tidsram: immediately before (week 1) and after (week 12) the PR program
|
The Timed Up and Go (TUG) test is a functional balance test in which the time needed to perform the test is recorded.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in health-related quality of life
Tidsram: immediately before (week 1) and after (week 12) the PR program
|
The St. George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure quality of life in patients with chronic lung disease.
It has 3 domains: symptoms, activities and impact.
Higher scores indicate poorer quality of life.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Patients' perspectives about the intervention
Tidsram: Immediately after the PR program (week 12)
|
Semi-structured focus group interviews will be conducted with patients to explore their perspectives about the use of activity monitors and the feedback given.
|
Immediately after the PR program (week 12)
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Alda S. Marques, PhD, Aveiro University
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- SFRH /BD/81328/2011
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .